Welcome to CDC Stacks | Recommendations of the U.S. Public Health Service Task Force on the Use of Zidovudine to Reduce Perinatal Transmission of Human Immunodeficiency Virus - 7359 | Guidelines and Recommendations
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Recommendations of the U.S. Public Health Service Task Force on the Use of Zidovudine to Reduce Perinatal Transmission of Human Immunodeficiency Virus
Filetype[PDF - 358.36 KB]


Details:
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. Recommendations of the U.S. Public Health Service Task Force on the Use of Zidovudine to Reduce Perinatal Transmission of Human Immunodeficiency Virus
    Personal Author:
    Balsley, James; Mofenson, Lynne; Moseley, Robin R.; Rogers, Martha F.; Simonds, Robert J.;
    Corporate Author:
    United States, Public Health Service., Task Force on the Use of Zidovudine to Reduce Perinatal Transmission of Human Immunodeficiency Virus.; Center for Research for Mothers and Children (U.S.). ǂb Pediatric, Adolescent, and Maternal AIDS Branch; Centers for Disease Control and Prevention (U.S.); National Center for Infectious Diseases (U.S.), Division of HIV/AIDS.; National Institute of Allergy and Infectious Diseases (U.S.). ǂb Division of AIDS;
    Published:
    August 5, 1994
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 43, no. RR-11
    Description:
    These recommendations update the interim guidelines (1) developed by the U.S. Public Health Service for the use of zidovudine (ZDV) to reduce the risk for perinatal transmission of human immunodeficiency virus (HIV) infection. The recently reported r...
    File Type:
    Filetype[PDF - 358.36 KB]
  2. U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States
    Personal Author:
    Mofenson, Lynne M.
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.), Public Health Service Task Force.; National Center for HIV, STD, and TB Prevention (U.S.), Division of HIV/AIDS Prevention--Surveillance and Epidemiology.; United States, Public Health Service., Perinatal HIV Guidelines Working Group.;
    Published:
    November 22, 2002
    Series:
    Morbidity and mortality weekly report. Recommendations and reports ; v. 51, no. RR-18
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 51, no. RR-18
    Description:
    "These recommendations update the February 4,2002, guidelines developed by the Public Health Service for the use of zidovudine (ZDV) to reduce the risk for perinatal human immunodeficiency virus type 1 (HIV-1) transmission. This report provides healt...
    File Type:
    Filetype[PDF - 520.38 KB]
  3. U.S. Public Health Service Task Force recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-infected Women for Maternal Health and Interventions to Reduce Perinatal HIV-1 Transmission in the United States
    Corporate Author:
    Center for Research for Mothers and Children, National Institute of Child Health and Human Development, National Institutes of Health, USA.
    Source:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 2002; 51(RR-18):1-38; quiz CE1-4.
    Description:
    These guidelines replace CDC's 1994 guidelines, HIV Counseling, Testing, and Referral Standards and Guidelines, and contain recommendations for public- and private-sector policy makers and service providers of human immunodeficiency virus (HIV) couns...
    Status:
    superseded
    File Type:
    Filetype[PDF - 520.38 KB]
  4. Public Health Service Task Force Recommendations for the Use of Antiretroviral Drugs in Pregnant Women Infected with HIV-1 for Maternal Health and for Reducing Perinatal HIV-1 Transmission in the United States. Centers for Disease Control and Prevention
    Source:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 1998; 47(RR-2):1-30.
    Description:
    This document contains revised guidelines developed by CDC for laboratories performing lymphocyte immunophenotyping assays in human immunodeficiency virus-infected persons. The recommendations in this document reflect CURRENT technology in a field th...
    Status:
    superseded
    File Type:
    Filetype[PDF - 339.54 KB]
  5. Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States
    Corporate Author:
    Division of HIV/AIDS, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA.
    Status:
    current
    File Type:
    Filetype[PDF - 155.10 MB]